StayCalm 42

Queensland, Australia

Short Summary

Leopa BioHealth holds the licencing contract for the commercialisation of StayCalm 42, a revolutionary and scientifically proven stress-relieving beverage.


  • StayCalm 42 has been proven through clinical studies to reduce stress
  • Leopa BioHealth holds the global licence to commercialise StayCalm 42
  • StayCalm 42 is ready for commercialisation
  • StayCalm 42 has a global potential in health and well-being, and livestock
  • Estimated total sales $1,712,000 within 12 months of product launch
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.


Investment Raised
Previous Rounds HK$2,700,000
Stage MVP/Finished Product
Investor Role Silent

Want to pitch on Angel Investment Network?

It’s easy to create a pitch using our online form. Your pitch can be in front of our 204,810 investors before you know it.

Create New Account
Already have an account?

Similar Projects

Global Pro
82% raised

25x ROI over 3 Years

location_on Queensland, Australia

Natural Skin Care. 25x Return on Investment over 3 years. Leader & Pioneer with 18 experience. Previous investors had offers of $1.1M from $50k investment.

HK$ 2,700,000


HK$ 55,000

Min per Investor

Global Pro
35% raised

Profitable General Store

location_on Western Australia, Australia

16.12% P.A Return on Investment. Invest into a Strong, Profitable Long Standing Business. General Store sells under one roof, Hardware, Grocery, Chemicals/Fertilisers, Liquor Store and Post Office/boxes with no competitors within 70Km.

HK$ 1,100,000


HK$ 160,000

Min per Investor

Global Pro
0% raised

Lucidium Qro

location_on New South Wales, Australia

The patient-centric, digital platform harnessing the power of AI and blockchain to revive the entire clinical trial value chain leading to faster and affordable medicines. This is combined with 100% privacy and security of patient's personal data.

HK$ 27,000,000


HK$ 2,700,000

Min per Investor

load one similar proposal